SERVICES
Investments
The depth of our work in pharmaceutical & biotech companies has allowed us to develop a methodology that is based on the best practices in licensing. Based on extensive primary and secondary market research, we provide a comprehensive support to clients and can help identify, connect and negotiate with prospective licensees.

ITUA Health’s due diligence consultants have been a trusted DD source for over fifteen years, conducting assignments for large pharma, biotech, universities and investors. Every due diligence we perform is underpinned by our ability to incorporate individuals who have the exact matching expertise required for a tailored, thorough and accurate assessment.
Our core due diligence team draws from a 250-member network of consulting specialists, each with a minimum of 20 years of industry experience. This allows us to assemble DD teams that incorporate consultants highly experienced in the exact functional discipline, product modality, or disease area of the asset, program or company being evaluated, resulting in assessments that are precisely on target.
+34 644 18 70 08
info@ituahealth.com

We evaluate early stage research projects from a commercial, IP, business and technological perspective across the whole of healthcare with the objective of ranking them according to the market opportunity, market access and the priorities of the clients.
We carry out a technological mapping, recommending the projects with the greatest technical and market viability depending on the health sector to which they belong with define a clear ranking of assets.
+34 644 18 70 08
info@ituahealth.com
High impact health and biotechnology consulting services that drive disruptive technologies with agility to speed innovation and improve outcomes.
We excel in evaluating and expediting early-stage technologies, with a focus on optimizing their commercialization through licensing or start-up creation.
2024 All rights reserved – LEGAL ADVISE | COOKIES | PRIVACITY POLICY